Neurol. praxi. 2020;21(4):283-286 | DOI: 10.36290/neu.2020.082

Migraine and multiple sclerosis - symptom or comorbidity

doc. MUDr. Radomír Taláb, CSc.1, MUDr. Marika Talábová2
1 MS Centrum Teplice, Centrum pro diagnostiku a léčbu bolestí hlavy, Hradec Králové
2 Neurologická klinika LFUK a FN, Hradec Králové

The increased incidence of headache in MS patients compared to a healthy population is generally known. Prevalence in individual studies, in their meta-analyses and in individual published MS patient populations has a large dispersion of 4-64 %. It turns out that there is an increased incidence of headache in the early stage of MS and during relapse and are likely equivalent to an inflammatory reaction on meninges in MS patients. In this sense, headaches, migraine or a tension type of headache (TTH) can be understood as a symptom of MS. Several drugs used in the treatment of MS can cause headaches or decompensate migraine, worsen quality of life and drug adherence. In the case of classification of primary headache as comorbidity of MS, specific treatment should be initiated.

Keywords: headaches, multiple sclerosis, migraine, tension type headache, comorbidity.

Received: July 17, 2020; Revised: July 17, 2020; Accepted: July 17, 2020; Prepublished online: July 17, 2020; Published: September 8, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Taláb R, Talábová M. Migraine and multiple sclerosis - symptom or comorbidity. Neurol. praxi. 2020;21(4):283-286. doi: 10.36290/neu.2020.082.
Download citation

References

  1. Elmazny A, Hamdy SM, Abddel-Naseer M, Shalaby NM, Shehata HS, Kishk NA, Nada MA, Mourad HS, Hegazy MI, Abddelalim A, Ahmed SM, Hatem G, Fouad AM, Mahnoud H, Hassan A. Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization. Journal of Pain Researche 2020; 13: 537-545. Go to original source... Go to PubMed...
  2. Gebhardt M, Kropp P, Jurgens TP, Hoffmann F, Zettl UK. Headache in the first manifestation of Multiple Sclerosis - Prospective multicenter study. Brain and Behavior 2017; 7: e00852. https://doi.org/10.1002/brb3.852. Go to original source... Go to PubMed...
  3. Graziano E, Hageeier J, Weinstock-Guttman B, Ramasamy DP, Zivadinov R. Increased contrast enhancing lesion aktivity in relapsing-remitting multiple sclerosis migraine patients. NeuroImage: Clinical 2015; 9: 110-116. Go to original source... Go to PubMed...
  4. Greb E. Comorbid Migraine and Multiple Sclerosis Can pose Challenges for Neurologists. Neurology Reviews 2012; 20(4): 1-8 p.
  5. Huges GRV. Migraine, memory loss, and "multiple sclerosis". Neurological features of the antiphospholipid (Huges')syndrome. Postgrad Med J 2003; 79: 81-83. Go to original source... Go to PubMed...
  6. International Headache Society 2018. The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38(1): 1-211. Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0333102417738202. Go to original source... Go to PubMed...
  7. Joshi S, Yau W, Kermode A. CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags. J Clin Neurosci 2017; 35: 75-77. Go to original source... Go to PubMed...
  8. Kister I, Caminero AB, Monteith TS, Soliman A, Bacon TE, Bacon JH, Kalina JT, Inglese M, Herbert J, Lipton RB. Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain 2010; 11: 417-425. Go to original source... Go to PubMed...
  9. Kubala Havrdová E, Piťha J. Klinický doporučený postup pro diagnostiku a léčbu roztroušené sklerózy a neuromyelitis optica a onemocněnî jejîho širšîho spektra, verze 2.0 2020, dostupné z https://www.czech-neuro.cz/content/uploads/2020/04/rs_odborna-2.0_final_pub_web-2.pdf.
  10. Möhrke J, Kropp P, Zettl UK. Headaches in Multiple Sclerosis Patients Might Imply an Inflammatorial Process. PLOS ONE August 2013; 8(8): e69570. www.plosone.org. Go to original source... Go to PubMed...
  11. Pecckel L. Significance and Prevalence of Headache in Multiple Sclerosis. Advisor Channels: Headache Migraine Advisor, April 15, 2019.
  12. Tabby D, Majeed MH, Youngman B, Wilcox J. Headache in Multiple Sclerosis. Int J MS Care 2013; 15: 73-80. Go to original source... Go to PubMed...
  13. Terlizzi R, Merli E, Buccellato E, Giannini G, Favoni V, Pierangeli G, Salvi F, Cortelli P, Cevoli S. Headache in multiple sclerosis: prevalence and clinical features in a case control-study. J Headache Pain 2015; 16(Suppl. 1): A83; http://www.thejournalofhedeacheandpain.com/content/16/S1/A83. Go to original source... Go to PubMed...
  14. Thomson AJ, Banwell BL, Barkhof F, Carrol WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Wabaunt E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology 2018; 17(2): 162-173. DOI: https://doi.org/10.1016/S1474-4422(17)30470-2. Go to original source... Go to PubMed...
  15. Togha M, Khoshsurat NA, Moghadasi AN, Mousavinia F, Mozafari M, Neishaboury M, Mousavi SM. Headache in relapse and remission phase of multiple sclerosis: A case-control study. Iran J Neurol 2016; 15(1): 1-8. http://ijnl.tums.ac.ir.
  16. Watkins SM, Espir M. Migraine and multiple sclerosis. J Neurol Neurosurg Psychiat 1969; 32: 35-37. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.